| 000 | 01905 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250516041802.0 | ||
| 264 | 0 | _c20111010 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1471-2172 | ||
| 024 | 7 |
_a10.1186/1471-2172-12-35 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSprague, Leslee | |
| 245 | 0 | 0 |
_aThe interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells. _h[electronic resource] |
| 260 |
_bBMC immunology _cJun 2011 |
||
| 300 |
_a35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiogenic Proteins _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Culture Techniques _xmethods |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCollagen |
| 650 | 0 | 4 |
_aCollagen Type I _xpharmacology |
| 650 | 0 | 4 |
_aDendritic Cells _xdrug effects |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibronectins _xpharmacology |
| 650 | 0 | 4 |
_aGelatin _xpharmacology |
| 650 | 0 | 4 | _aLaminin |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMyeloid Cells _xdrug effects |
| 650 | 0 | 4 | _aPolylysine |
| 650 | 0 | 4 | _aPolystyrenes |
| 650 | 0 | 4 | _aProteoglycans |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aMuccioli, Maria | |
| 700 | 1 | _aPate, Michelle | |
| 700 | 1 | _aMeles, Evan | |
| 700 | 1 | _aMcGinty, John | |
| 700 | 1 | _aNandigam, Harika | |
| 700 | 1 | _aVenkatesh, Amritha K | |
| 700 | 1 | _aGu, Ming-Yu | |
| 700 | 1 | _aMansfield, Kristen | |
| 700 | 1 | _aRutowski, Andrew | |
| 700 | 1 | _aOmosebi, Omowaleola | |
| 700 | 1 | _aCourreges, Maria C | |
| 700 | 1 | _aBenencia, Fabian | |
| 773 | 0 |
_tBMC immunology _gvol. 12 _gp. 35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2172-12-35 _zAvailable from publisher's website |
| 999 |
_c20903560 _d20903560 |
||